|
Symposium
[Free Online] The Science and Stories of Promising Biotech Startups
Speakers:
Ritu Lal, Gen1E Lifesciences; Shilpa Sambashivan, Nura; Stefan Ryser, Trellis Bio; Keting Chu, Bluejay; Annahita Keravala, Genascence; Shelley Force Aldred, Rondo Therapeutics; Donald McCarthy, Samsara BioCapital
Organizers:
Toby Freedman (Synapsis Search); Sarah Bodary (AbCellera); Donald McCarthy (Samsara BioCapital); Shichang Miao (PBSS)
Date:
2023-08-17
Time:
8:30-13:30 Pacific Time
Registration fee:
0
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-08-16
(it will close sooner if the seating cap is reached)
About the Topic
This symposium series aims to provide a platform for promising biotech startup companies to highlight their science and share their stories in building a fledgling business.
Pacific Time
|
Eastern Time
|
Topic
|
Presenter
|
8:30 - 8:40 am
|
11:30 -11:40 am
|
Welcome Remarks
|
Shichang Miao, PBSS
|
8:40 - 9:15 am
|
11:40 am -12:15 pm
|
Clinical-Stage Company in Phase 2 with a Multi-Target AI Platform Accelerating Therapies for Inflammatory and Rare Diseases
|
Ritu Lal, M.S, PhD, CEO, Gen1e Lifesciences Inc.
|
9:15 -9:50 am
|
12:15 - 12:50 pm
|
Discovery and Development of Neuroprotective Therapies for the Treatment of Neurological Diseases
|
Shilpa Sambashivan, PhD, CSO, Nura Bio Inc.
|
9:50 -10:25 am
|
12:50 - 1:25 pm
|
Clinical Proof-of-Concept in a Difficult-to-Treat Infection, human mAb TRL1068 Overcomes Antibiotic Resistance Due to Bacterial Biofilm
|
Stefan Ryser, PhD, President & CEO, Trellis Bioscience, Inc.
|
10:25 -11:00 am
|
1:25 - 2:00 pm
|
Development of Functional Cure for Chronic HBV Infection
|
Keting Chu, MD, PHD, CEO & Founder, Bluejay Therapeutics, Inc.
|
11:00 -11:10 am
|
2:00 - 2:10 pm
|
Break Time
|
|
11:10 - 11:45 pm
|
2: 10 – 2:45 pm
|
AAV-Mediated Gene Therapy for Osteoarthritis
|
Annahita Kervala, PhD, CSO, Genascence
|
11:45 am- 12:20 pm
|
2:45 – 3:20 pm
|
Tackling Solid Tumors with Next-Generation Bispecific Antibodies
|
Shelley Force Aldred, PhD, CEO & Co-founder, Rondo Therapeutics
|
12: 20 – 12:55 pm
|
3:20 – 3:55 pm
|
Raising capital in today's environment
|
Donald McCarthy, PhD, VP, Samsara BioCapital
|
12:55 – 1:30 pm
|
3:55 – 4:30 pm
|
Panel Discussion
|
All Speakers
|
The Zoom link will be sent one day before the symposium.
2023-10-06, [In-Person] Human PK and Dose Prediction for Small Molecules
|
2023-11-07, [Free Online] The Science and Stories of Promising Biotech Startups
|
2023-11-13, [In-Person] Clinical Pharmacology Across the Drug Development Continuum: Key Clinical Studies, Modeling & Simulation to Support Drug Approval and Labeling
|
2023-12-06, [Free Online] Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery & Development
|
2024-01-19, [In-Person] ADME/DMPK Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
|
Alturas Analytics, Inc.
Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
|
ICON
Innovation Workshop in SF Bay Area: Bringing the trial to the patient: Are you driving true patient centricity? Oct 19, Crowne Plaza Foster
|
Viva Biotech
Join Viva Reception if you have a need in MedChem, SBDD, FBDD, CryoEM, ASMS, SPR, HDX, CADD, Bioassay, CMC, Ab, https://www.bagevent.com/event/8673557
|
BioTether Sciences
Bioanalytical CRO, focused on PK, Biomarkers, and Immunogenicity. Custom Assay development, validation and testing. Advanced cell engineering.
|
Submit a Text Ad
|